Clinical Trials Directory

Trials / Completed

CompletedNCT02084849

ADPKD Cohort Study

The Autosomal Dominant Polycystic Kidney Disease (ADPKD) Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
624 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out if radiology tests of the kidneys as opposed to glomerular filtration (GFR) tests (GFR test - a lab test that measures kidney function) follow progression of polycystic kidney disease (PKD) the best. PKD patients at risk for progression to renal failure (dialysis or transplantation) have been identified and include those who have been diagnosed with high blood pressure early, the presence of the PKD1 gene (the inherited abnormality responsible for the majority of PKD), men as opposed to women, those with episodes of visible blood or increased protein in their urine, and women who have experience more than three pregnancies. Individuals who are diagnosed with PKD in the first year of life or in utero (before birth) are also at high risk for progression to renal failure. This study will also facilitate understanding of human diseases at the cellular and molecular level. We will be identifying genetic factors that may influence the severity of polycystic kidney disease (PKD). You are being asked to provide a sample of blood for the purpose of DNA or other biochemical analyses.

Conditions

Timeline

Start date
1998-06-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2014-03-12
Last updated
2015-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02084849. Inclusion in this directory is not an endorsement.

ADPKD Cohort Study (NCT02084849) · Clinical Trials Directory